FYERS
Orchid Pharma952.05
+17.40 (+1.86%)

Orchid Pharma Share Price

952.05+17.40 (+1.86%)
+28.71% past 1 Year

News

Orchid Pharma to commence 7-ACA plant operations by March 2027

Equity
ORCHPHARMA
24 Aug 2026

Orchid Pharma inks exclusive Exblifep licensing deal with Russian firm Pharmasyntez

Equity
ORCHPHARMA
7 Jul 2026

Orchid Pharma projects significant global sales potential for key antibiotic combo

Equity
ORCHPHARMA
16 Jun 2026

Orchid Pharma nears US licensing deal for novel antibiotic candidate

Equity
ORCHPHARMA
16 Jun 2026

Orchid Pharma gains NCLT nod for merger with Dhanuka Lab to scale operations

Equity
ORCHPHARMA
12 Jun 2026

Orchid Pharma informs about investor presentation

Equity
ORCHPHARMA
26 May 2026

Orchid Pharma reports Profit after tax of 30.60 Crores, in the March 2026 quarter

Equity
ORCHPHARMA
25 May 2026

Orchid Pharma Q4 EBITDA declines year-on-year with lower operating margin performance

Equity
ORCHPHARMA
25 May 2026

Orchid Pharma Q4 FY earnings: flat revenue, modest profit growth YoY

Equity
ORCHPHARMA
25 May 2026

NCLT Rejects DBS Bank's Lease Rent Claim Against Orchid Pharma in CIRP Proceedings

Equity
ORCHPHARMA
11 Apr 2026

Orchid Pharma Q3 FY2026 Results: Sharp EBITDA Decline and Consolidated Loss

Equity
ORCHPHARMA
11 Feb 2026

Orchid Pharma Q3 FY2025 Consolidated Net Loss of Rs 12.60 Crores vs YoY Profit.

Equity
ORCHPHARMA
11 Feb 2026

Orchid Pharma reports Profit after tax of Rs -5.83 Crores, in the December 2025 quarter

Equity
ORCHPHARMA
11 Feb 2026

Orchid Pharma aims for FY26 revenue growth with capacity, product pipeline, and Chennai plant commissioning.

Equity
ORCHPHARMA
11 Nov 2025

Orchid Pharma reports Profit after tax of 2.23 Crores, in the September 2025 quarter

Equity
ORCHPHARMA
11 Nov 2025

Orchid Pharma reports Q2 FY25 earnings with EBITDA of Rs 37.5 crores; revenue rose 12% YoY.

Equity
ORCHPHARMA
11 Nov 2025

Orchid Pharma reports Q2 FY25 consolidated net loss of Rs 5.70 crores versus Rs 25.60 crores profit year-on-year.

Equity
ORCHPHARMA
11 Nov 2025

Orchid Pharma: Co Aims To Cut Costs And Maintain Margins Due To Weak Sales; Using Api Portfolio, Export Chances, And Efficiency To Boost Medium-Term Revenue And Profit Growth. ??

Equity
ORCHPHARMA
12 Aug 2025

Orchid Pharma: Q1 Ebitda 14.20 Crores Rupees Vs 32.50 Crores (Yoy) || Q1 Ebitda Margin 8.19% Vs 13.29% (Yoy)

Equity
ORCHPHARMA
12 Aug 2025

Orchid Pharma: Q1 Cons Net Profit 14.90 Crores Rupees Vs 29.40 Crores (Yoy) || Q1 Revenue 173.00 Crores Rupees Vs 240.00 Crores (Yoy)

Equity
ORCHPHARMA
12 Aug 2025

Orchid Pharma Ltd Share Price Today

The Orchid Pharma Ltd share price today is ₹939.10. During the trading session, the Orchid Pharma Ltd share price opened at ₹936.00 and recorded an intraday high of ₹954.75 and a low of ₹933.40. Last closing price was ₹938.05. Over the past 52 weeks, the Orchid Pharma Ltd share price has ranged between ₹480.00 and ₹1,133.00. The current Orchid Pharma Ltd stock price reflects real-time market activity based on executed trades on the exchange.